María Josefa Pajares Villandiego-rekin lankidetzan egindako argitalpenak (2)

2011

  1. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166

2010

  1. TGFBI expression is associated with a better response to chemotherapy in NSCLC

    Molecular Cancer, Vol. 9